Skip to content
healthcare.dev

NIVAGEN ZINC OXIDE

NDC 75834-170, zinc oxide, ointment, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-170
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZINC OXIDE200 mg/g
Package NDCNDC-11Package
75834-170-017583401700128.4 g in 1 TUBE (75834-170-01)
75834-170-027583401700256.7 g in 1 TUBE (75834-170-02)
75834-170-1575834017015425 g in 1 JAR (75834-170-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 75834017001

    GET /v1/drugs/nadac/75834017001
  • NADAC price for package 75834017002

    GET /v1/drugs/nadac/75834017002

Use it

Look up 75834-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.